A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Citadel Advisors LLC holds 4,200 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,200
Previous 29,800 85.91%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
N/A
42,437 New
42,437 $0
Q3 2023

Nov 14, 2023

BUY
N/A
6,915 Added 10.11%
75,321 $0
Q2 2023

Aug 14, 2023

BUY
N/A
68,406 New
68,406 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $833,362
83,755 New
83,755 $0
Q2 2022

Aug 15, 2022

SELL
$8.84 - $11.64 $250,357 - $329,656
-28,321 Reduced 61.76%
17,539 $175,000
Q1 2022

May 16, 2022

SELL
$10.07 - $11.93 $42,716 - $50,607
-4,242 Reduced 8.47%
45,860 $531,000
Q2 2021

Aug 16, 2021

SELL
$9.91 - $12.78 $104,312 - $134,522
-10,526 Reduced 17.36%
50,102 $563,000
Q1 2021

May 17, 2021

BUY
$10.44 - $12.22 $19,136 - $22,399
1,833 Added 3.12%
60,628 $643,000
Q4 2020

Feb 16, 2021

BUY
$9.3 - $11.77 $546,793 - $692,017
58,795 New
58,795 $638,000
Q2 2020

Aug 14, 2020

SELL
$7.96 - $11.54 $185,786 - $269,343
-23,340 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$7.69 - $11.68 $77,553 - $117,792
10,085 Added 76.08%
23,340 $203,000
Q4 2019

Feb 14, 2020

SELL
$9.09 - $11.89 $45,604 - $59,652
-5,017 Reduced 27.46%
13,255 $150,000
Q3 2019

Nov 14, 2019

BUY
$9.66 - $12.36 $61,978 - $79,301
6,416 Added 54.12%
18,272 $198,000
Q2 2019

Aug 14, 2019

SELL
$9.32 - $12.98 $21,911 - $30,515
-2,351 Reduced 16.55%
11,856 $111,000
Q3 2018

Nov 13, 2018

BUY
$12.65 - $15.15 $179,718 - $215,236
14,207 New
14,207 $0
Q4 2017

Feb 09, 2018

SELL
$11.65 - $13.35 $169,530 - $194,269
-14,552 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$11.95 - $13.35 $173,896 - $194,269
14,552
14,552 $188,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.